Windham Life Sciences Partners IV, L.P. is a venture capital fund based in New York, New York. According to its most recent Form D, filed Nov 13, 2025, it has sold $30,784,955 of interests to 51 investors since its first sale in Oct 2023. The minimum investment it accepts from an outside investor is $1. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Windham Life Sciences Partners General Partner IV, LLC; Adam Fine.
- Total raised
- $30,784,955Cumulative sales reported on Form D
- Investors
- 51
- First sale
- Oct 27, 2023
- Minimum investment
- $1
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Windham Life Sciences Partners General Partner IV, LLC; Adam Fine
- Latest Form D
- Nov 13, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Windham Life Sciences Partners IV, L.P.
What is the minimum investment for Windham Life Sciences Partners IV, L.P.?
According to its latest Form D, filed Nov 13, 2025, the minimum investment Windham Life Sciences Partners IV, L.P. accepts from an outside investor is $1.
Who can invest in Windham Life Sciences Partners IV, L.P.?
Windham Life Sciences Partners IV, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Windham Life Sciences Partners IV, L.P. raised?
Windham Life Sciences Partners IV, L.P. reports $30,784,955 sold from 51 investors on its Form D filed Nov 13, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Windham Life Sciences Partners IV, L.P. based?
Windham Life Sciences Partners IV, L.P. is based in New York, New York.
When did Windham Life Sciences Partners IV, L.P. launch?
Windham Life Sciences Partners IV, L.P. reports its first sale in Oct 2023, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every venture capital fund
Raised more than 89% of the 1,252 venture capital funds based in New York, and more than 94% of all 15,160 that report sales.